An observational study in Dry Eye Syndromes, sponsored by TearScience, Inc.. Completed at 8 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-03-31.
Sponsored by TearScience, Inc. · Observational
The objectives of this study are to assess for a difference between normal and dry eye subjects in tear film quality using a diagnostic interferometry device and to determine whether there are associations between tear film quality and dry eye symptoms and signs.
1,292 studies on the registry are indexed under Dry Eye Syndromes; 191 are open to participants now.
This study's enrollment of 229 is above the median of 90 across 171 observational studies indexed under Dry Eye Syndromes.
Browse Dry Eye Syndromes studies →TearScience, Inc. is the lead sponsor of 6 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects undergoing routine eye examination in ophthalmic practices
Exclusion Criteria:
Any of the following conditions within specified timeframe prior to study participation:
Subjects without dry eye symptoms based on questionnaire.
Device: Tear Film Analyzer
Subjects with dry eye symptoms based on questionnaire.
Device: Tear Film Analyzer
tear film images
Also known as: ocular surface interferometry
Tear film analysis of lipid layer quality
Time frame: upon enrollment
Dry Eye Symptoms
Time frame: upon enrollment
Tear Film Break-Up Time
Time frame: upon enrollment
Corneal and Conjunctival Staining
Time frame: upon enrollment
Meibomian Gland Assessment
Time frame: upon enrollment
Schirmer Test
Time frame: upon enrollment
This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
TearScience, Inc.